Filing Details
- Accession Number:
- 0000904454-24-000650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-12 16:54:07
- Reporting Period:
- 2024-12-10
- Accepted Time:
- 2024-12-12 16:54:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536290 | C Matthew Kapusta | C/O Uniqure, N.v. Amsterdam P7 11058BP | Ceo, Managing Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2024-12-10 | 100,000 | $14.71 | 697,915 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-12-10 | 100,000 | $15.03 | 597,915 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2024-12-10 | 100,000 | $0.00 | 100,000 | $14.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-01-02 | No | 4 | M | Direct |
Footnotes
- The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on August 12, 2024 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The Reporting Person's 10b5-1 trading plan relates solely to options to purchase Ordinary Shares scheduled to expire in the near-term, including those reported herein, which were scheduled to expire on January 1, 2025, and 100,000 options with an exercise price of $23.60 scheduled to expire on August 25, 2025.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.14. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The Stock Option vested 25% on January 2, 2016 and 6.25% quarterly thereafter.
Billionaire Hedge Funds
